✦ LIBER ✦

75 Mechanisms of Resistance to Anti-VEGF Treatment – New Therapeutic Strategies

✍ Scribed by A. Harris

Book ID: 117662616
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 50 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(12)70779-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A potential therapeutic strategy for inh

A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents

✍ Hamid Hosseini; Mahmood Nejabat 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Glioblastoma angiogenesis: VEGF resistan

Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation

✍ Shingo Takano 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 434 KB

Mechanisms of resistance to tyrosine kin

Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance

✍ Bixby, D.; Talpaz, M. 📂 Article 📅 2009 🏛 American Society of Hematology 🌐 English ⚖ 280 KB

[Advances in Biological Psychiatry] Ther

[Advances in Biological Psychiatry] Therapy-Resistant Schizophrenia Volume 26 || New Therapeutic Strategies for Resistance to Clozapine and Treatment-Resistant Schizophrenia

✍ Elkis, H.; Meltzer, H.Y. 📂 Article 📅 2010 🏛 KARGER ⚖ 173 KB

Resistance to HER2-targeted therapy: mec

Resistance to HER2-targeted therapy: mechanisms of trastuzumab resistance and possible strategies to overcome unresponsiveness to treatment

✍ Michael Hubalek; Christine Brunner; Karin Matthä; Christian Marth 📂 Article 📅 2010 🏛 Springer Vienna 🌐 German ⚖ 246 KB

Inhibition of tumor angiogenesis as a st

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

✍ Robert S. Kerbel 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 774 KB

Cancers have a formidahle capacity to develop resistance to a large and diverse array of chemical, biologic, and physical anti-neoplastic agents. This can be largely traced to the instability of the tumor cell genome, and the resultant ability of tumor cell populations to generate phenotypic variant